Title
Alkanediamide-Linked Bisbenzamidines are Promising Antiparasitic Agents
Funding Source
NIMHD-NIH
Grant Number
2G12MD007595
Department
College of Pharmacy
Document Type
Article
Publication Date
6-2016
Abstract
A series of 15 alkanediamide-linked bisbenzamidines and related analogs was synthesized and tested in vitro against two Trypanosoma brucei (T.b.) subspecies: T.b. brucei and T.b. rhodesiense, Trypanosoma cruzi, Leishmania donovani and two Plasmodium falciparum subspecies: A chloroquine-sensitive strain (NF54) and a chloroquine-resistant strain (K1). The in vitro cytotoxicity was determined against rat myoblast cells (L6). Seven compounds (5, 6, 10, 11, 12, 14, 15) showed high potency against both strains of T. brucei and P. falciparum with the inhibitory concentrations for 50% (IC50) in the nanomolar range (IC50 = 1-96 nM). None of the tested derivatives was significantly active against T. cruzi or L. donovani. Three of the more potent compounds (5, 6, 11) were evaluated in vivo in mice infected with the drug-sensitive (Lab 110 EATRO and KETRI 2002) or drug-resistant (KETRI 2538 and KETRI 1992) clinical isolates of T. brucei. Compounds 5 and 6 were highly effective in curing mice infected with the drug-sensitive strains, including a drug-resistant strain KETRI 2538, but were ineffective against KETRI 1992. Thermal melting of DNA and molecular modeling studies indicate AT-rich DNA sequences as possible binding sites for these compounds. Several of the tested compounds are suitable leads for the development of improved antiparasitic agents.
Recommended Citation
Vanden Eynde, J. J.; Mayence, A.; Mottamal, M; Bachi, C. J.; Yarlett, N.; Kaiser, M.; Brun, R.; and Huang, T. L., "Alkanediamide-Linked Bisbenzamidines are Promising Antiparasitic Agents" (2016). Faculty and Staff Publications. 154.
https://digitalcommons.xula.edu/fac_pub/154
Comments
DOI: 10.3390/ph9020020
Funding text
The work described in this manuscript has been funded in part by the (NIMHD-NIH) under grant number 2G12MD007595.